TP53 and posterior cortical atrophy: TP53 mutation was also associated with the increased aggressiveness and poor prognosis of PCa, and the TP53 mutation-based mutation signature could predict patients’ outcomes (48), which was consistent with our results that PCa patients with TP53 mutation had higher riskscores, indicating poor prognosis.